1. Home
  2. ETY vs ANIP Comparison

ETY vs ANIP Comparison

Compare ETY & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest

ETY

Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest

HOLD

Current Price

$15.04

Market Cap

2.4B

Sector

Finance

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$80.34

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETY
ANIP
Founded
2006
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ETY
ANIP
Price
$15.04
$80.34
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$107.33
AVG Volume (30 Days)
247.3K
543.8K
Earning Date
01-01-0001
02-27-2026
Dividend Yield
7.21%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.67
Revenue
N/A
$826,880,000.00
Revenue This Year
N/A
$44.19
Revenue Next Year
N/A
$11.25
P/E Ratio
N/A
$48.86
Revenue Growth
N/A
48.87
52 Week Low
$10.59
$54.10
52 Week High
$13.46
$99.50

Technical Indicators

Market Signals
Indicator
ETY
ANIP
Relative Strength Index (RSI) 44.37 45.67
Support Level $14.74 $78.79
Resistance Level $15.37 $83.80
Average True Range (ATR) 0.20 2.64
MACD -0.02 -0.14
Stochastic Oscillator 50.79 25.82

Price Performance

Historical Comparison
ETY
ANIP

About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: